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AhStIWt 
In Escherichia coli, an elongation factor (EF-Tu-like) specific to SeCys-tRNA, SELB, has been identified; however, a mammalian counterpart of 
SELB has not been reported to date. We searched for and found this factor in bovine liver extracts using the assay of [‘%e]SeCys-tRNA protecting 
activity against alkaline hydrolysis (SePF activity). We found SePF activity in the protein extracts of the precipitate (microsomal fraction) collected 
at 150,008 x g from bovine liver. The proteins were separated by Sephacryl S-300 chromatography, and the SePF and EF-la activities were found 
in the same fraction, indicating that SePF and EF-la have the same molecular mass (approximately 50 kDa). We then chromatographed this active 
fraction using CM-Sephadex C-25 columns. The SePF activity was eluted after the peak of EF-la activity. This result indicated that this SePF activity 
was not dependent on EF-la. In addition to performing these two chromatographies, we investigated pure EF-lo from Bombyx mori but could not 
detect any SePF activity in B. mori EF-la. Thus we showed that the SePF activity in bovine liver differs from that of EF-la in eukaryotes. Therefore 
the factor protecting [‘%e]SeCys-tRNA in bovine liver is not EF-la and must be a SELB-like factor. 
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1. Introduction 
Selenium is found as selenocysteine (SeCys) in mam- 
malian glutathione peroxidase (GSHPx) [ 11, type- 1 iodo- 
thyronine deiodinase [2], and selenoprotein P [3]. SeCys 
plays an important role at these active sites and shares 
a UGA codon with a stop codon. Using [‘%e]HSe- we 
have studied the mechanism of mammalian SeCys-tRNA 
synthesis [4,5]. The tRNA corresponding to UGA can 
accept serine, and this serine moiety is converted to 
SeCys on the tRNA. Then SeCys-tRNA is co-transla- 
tionally incorporated into selenoproteins at the position 
of UGA [4]. However, the mechanisms of incorporating 
SeCys into selenoproteins in mammals are still unclear. 
factor dithering in function to EF-Tu and transports only 
SeCys-tRNAWs to ribosomes [8]. SELB has a higher 
molecular mass (68 kDa) relative to that of EF-Tu (43 
kDa) and is composed of two regions, i.e. the region for 
stem-loop structure recognition and the EF-Tu-like re- 
gion [9]. tRNASeCys in E. coli has an unusual structure: 
a long variable arm and an 8 bp acceptor stem to which 
EF-Tu cannot bind; thus this is the discriminating factor 
rendering SeCys-tRNA_” specific to SELB [lo]. Al- 
though it is known that SELB plays a key role in decod- 
ing UGA-SeCys in E. coli, the UGA-SeCys decoding 
mechanisms in mammals are still unclear. 
On the other hand, SeCys is also found in the active 
site of Escherichia coli formate dehydrogenase (FDH) 
[6]. For FDH, the SeCys incorporation mechanism has 
been clarified by A. Bock et al. [7] as follows. The stem- 
loop structure located at the 3’ side of the SeCys UGA 
codon on mRNA is essential for incorporation of SeCys 
on to the SeCys UGA codon. However, this stem-loop 
structure at the 3’ side of the SeCys UGA codon is not 
found in mammalian selenoprotein mRNA; therefore, 
the mammalian UGA-SeCys decoding system may differ 
from that in E. coli. The stem-loop structure on FDH 
mRNA is recognized by SELB, which is an elongation 
In order to clarify the mechanisms of mammalian 
SeCys incorporation, we searched for a mammalian 
SELB-like factor. In this report we show that the activity 
protecting [‘%e]SeCys-tRNA against alkaline hydrolysis 
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tRNA* was prepared from bovine liver and chromatographed 
using a BD-cellulose c&mn, as described in [l 11. The tinal f&ion (1.5 
M NaCl) eluting from the column. which was rich in tRNA=*. did not 
contain major [RNA* and was further chromatographed using a Se- 
phadex A-50 column. The obtained tRNA=” fraction had a purity of 
approximately lo%, as measured by hybridization with a DNA probe 
specific to tRNA”. SerRS was purified from bovine liver, as de- 
scribed in [ 121. [“Se]HSe- was prepared from [‘%e]selenite by the enxy- 
matic method of Ganther 1131, described in detail in 141: the 6nal sneciflc 
radioactivity of [‘%e]HSe’ was 1.6 Cilmmol(6.0 r;hi). - 
[%e]SeCys-tRNA was prepared as described in [5]. tRNA=” (0.02 
nmol) in 20~1 of 0.2 M Tris-HCl (pH 7.4), 20 mM MgCl,, 20 mM KCl, 
20 mM mercaptoethanol, 0.4 mM serine, 10 mM ATP, and 5 pg SerRS 
was mixed with 10 ~1 of the above r’Se]HSe-, 5 pg of bovine SeCys 
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synthase (10 mg/ml) and 10~1 of a selenide-activating protein (1 mg/ml) 
and incubated at 30°C for 2 h. [“Se]SeCys-tRNA was collected by 
ethanol precipitation, after the addition of 1 ~1 acetic acid to protect 
[“Se]SeCys-tRNA. 
2.2. [“CJPhe-tRNA 
tRNAr”’ was extracted from bovine liver according to methods de- 
scribed in [ll]. tRNAPh” was partially purified by chromatography 
using BD-celhtlose and DEAE Senhadex A-50 columns and used as 
tRNAPhe. PheRS was prepared from bovine liver as follows. Bovine 
liver extracts in 10 mM Tris-HCl (pH 7.4), 0.25 M sucrose, 10 mM 
mercaptoethanol, were centrifuged at 150,000 x g, and the supernatant 
was chromatographed using DEAE-cellulose columns. The PheRS ac- 
tivity eluted at 0.1 M NaCl was used as PheRS. Preparation of [14c]Phe- 
tRNA was performed as described in [14] with some modifications. 
tRNAPbe (8 A,, units oer 10 ul) in 10 ul of 1.0 M imidaxole-HCl fnH 
8.0), 750 mM ECl, 15 ^ &I ATP, 40 m&i MgCl, and 2.5 mM DTT Gas 
mixed with 10 pl of [14c]Phe (50 Ci/ml) and PheRS for a final volume 
of 50 ~1. The mixture was incubated at 33°C for 30 min. After the 
incubation, [14C]Phe-tRNA was collected by ethanol precipitation. 
2.3. Assay of EF-la activity 
Ribosomes were prepared from bovine brain according to methods 
described in [ 151. The EF-la activity assay was performed by measuring 
the binding of (i4C]Phe-tRNA to ribosomes according to methods de- 
scribed in [14] and as follows. The standard assay mixture (final volume 
of 50 ~1) contained 50 mM Tris-HCl @H 7.5), 75 mM KCl, 0.2 mM 
DTT, 5 pug of BSA, 0.1 mM GMP-P(CH3P (unhydrolyzable GTP 
analogue; Sigma), 5 pg of poly(U), 0.5 A,, units of ribosomes, 16 pmol 
of [‘4C]Phe-tRNA (382 Ci/mol) and an appropriate amount of each 
fractionated protein. Incubation was performed for 5 min at 37°C and 
the reaction was terminated by the addition of 3 ml of cold wash buffer 
which contained 20 mM Tris-HCl (DH 7.5). 5 mM Ma(CH,COO), and 
100 mM NH,Cl. Finally, the reaition mixture wai’po&d onto a 
nitrocellulose membrane tilter (0.45 p pore size; Millipore), and the 
membrane was washed twice with 3 ml of wash buffer and dried. The 
radioactivity of the membrane was measured with a liquid scintillation 
counter. 
2.4. Assay of [75Se/SeCys-tRh’A protecting activity against alkaline 
hydrolysis (SePF assay) 
The SePF assay was performed as follows. The standard assay mix- 
ture (flnal volume of 50~1) contained 50 mM Tris-HCl (PH 7.5), 75 mM 
KCl, 0.2 mM DTT, 0.1 mM GMP-P(CH;TP, 5 pg BSA, r’Se]SeCys- 
tRNA (20 x 10-i* Ci) and an appropriate amount of each fractionated 
protein. Incubation was carried out for 10 min at 30°C. Generally, 
aminoacyl-tRNAs were labile and easily hydrolysed under these condi- 
tions (pH 7.5 for 30 mm). Alkaline hydrolysis was terminated by etha- 
nol precipitation, and free r’Se]SeCys liberated from tRNA was re- 
moved by centrifugation. [“Se]SeCys-tRNA protected in the precipitate 
was hydrolysed in 2 N ammonia for 60 min at 30°C. The solution was 
mixed with 2 ~01s. of ethanol and the mixture was re-centrifuged. The 
supematant was immediately analyzed by TLC on silica-gel G plates 
with (n-butanol:acetic acid: water, 4: 1: 1). After development, 
[‘?Se]S.&ys on the silica plate was detected and measured with a 
Bioimane Analvxer BAS 2000 (Fuiix). Authentic SeCvs was co-chroma- 
tographed and colored by the” ninhydrin reaction. The substrate 
[“Se]HSe- was co-precipitated with tRNA and appeared at the top of 
the TLC plates. 
2.5. Chromatography conditions 
Chromatography on Sephacryl S-300 column (3.6 x 67 cm) was per- 
formed with standard buffer composed of 10 mM Tris-HCl (pH 7.4) 
10 mM MgCl,, 10 mM mercap&ethanol and 5% (v/v) glycerol, and 
7 ml fractions were collected. Standard buffer with Wl.8 M KC1 (linear 
gradient) was used as the eluent for the CM-Sephadex C-25 column 
(0.6 x 25 cm), and 300~1 fractions were collected. Chromatography and 
preparation of proteins were done in a cold room at 4°C. 
3. Results 
Active proteins were prepared from a precipitate of 
bovine liver extracts collected at 150,000 x g, according 
to the same method for E. coli SELB preparation [8] 
with some modifications. Bovine liver (500 g) was ho- 
mogenized and mixed with 500 ml of extraction buffer 
composed of 10 mM Tris-HCl (PH 7.4), 0.25 M sucrose 
and 10 mM mercaptoethanol. The extract was centri- 
fuged at 600 x g for 10 min, and the supematant was 
further centrifuged at 24,000 x g for 10 min to remove 
mitochondria. The resultant supernatant was centri- 
fuged at 150,000 x g for 60 min to precipitate micro- 
somes, and the precipitate was washed with 10 mM Tris- 
HCl (pH 7.4), 10 mM MgCl*, 10 mM KCl, 10 mM 
mercaptoethanol and 0.15 M NH&l and centrifuged at 
150,000 x g for 60 min. This precipitate was extracted 
with high-salt buffer composed of 10 mM Tris-HCl (pH 
7.4), 10 mM MgCl,, 10 mM KCl, 10 mM mercaptoetha- 
no1 and 1.0 M NH&l, the extract was centrifuged at 
150,000 x g for 60 min, and the supernatant was col- 
lected. SePF activity was not detected in the 0.15 M 
NH,Cl wash but was found in this extract using 1 M 
NH&l (data not shown). Proteins in the supernatant 
were precipitated with ammoniumsulfate, at a final satu- 
ration of 66.7%. 
These proteins (180 mg of protein was obtained from 
500 g bovine liver) were chromatographed using a Se- 
phacryl S-300 column, and the results are shown in 
Fig. 1. The highest main EF-la activity, indicated by 
open circles, was found in fractions 27-30 and weak 
activity was found in fraction 20. This EF-la activity 
represents the binding of [‘4C]Phe-tRNA to ribosomes. 
[75Se]SeCys-tRNA protecting activity (SePF activity) 
was searched for in several eluted fractions and found in 
Fraction number 
Fig. 1. A chromatography pattern of bovine liver extracts using Se- 
phacryl S-300. 0, EF-la activity @mol/mg protein) which was meas- 
ured based on the binding of [14C]Phe-tRNA to ribosomes in the pres- 
ence of poly(U). l , SePF activity (pmol/mg protein) which is the activity 
protecting [7’Se]SeCys-tRNA against alkaline hydrolysis. The passed- 
through fractions were omitted. 
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Fig. 2. [7sSe]SeCys-tRNA protecting activity (SePF activity) of the eluates shown i Fig. 1. The results of autoradiography with the Bioimage Analyzer 
B&32000 are shown. Numbers indicate fraction numbers as plotted in Fig. 1. ‘No’ indicates control without added protein. 
fractions 29-31 based on the TLC [“Se]SeCys autoradi- 
ography results using BAS2000, as shown in Fig. 2. The 
SeCys bands in Fig. 2 indicate [‘%e]SeCys protected with 
SePF. The identity of [“Se]SeCys on the TLC plates was 
confirmed by co-chromatography with authentic SeCys. 
We detected ense bands in autoradiographs of fractions 
29 and 31, and concluded that these fractions contained 
SePF activity. The value of SePF activity was estimated 
based on the radioactivity of protected [“Se]SeCys minus 
that of [“Se]SeCys of the control lane (‘No’; no protein 
was added to the assay mixture). The relative values of 
SePF activity are plotted in Fig. 1 as closed circles; SePF 
activity was eluted in fractions of approximately 50 kDa 
proteins (S-l in Fig. 1). EF-la activity, indicated by open 
circles, was found in the same fractions. Since both SePF 
and EF- 1 a activities were detected in fraction S-l, it may 
be concluded that this EF-l& has SePF activity. How- 
ever, we demonstrate a difference between SePF and 
EF-la in the next section. 
We chromatographed this S-l fraction using CM- 
Sephadex C-25 columns. The separation pattern is 
shown in Fig. 3, in which the passed-through fractions 
are omitted. Fig. 4 shows the TLC [“Se]SeCys autoradi- 
ography results, indicating dense bands for fractions 30- 
38. The relative values of SePF activity are plotted in Fig. 
3. EF-la activity was eluted in a pattern similar to that 
of the protein elution (absorbance at 280 nm); however, 
SePF activity was found in fractions 30-38, after the 
protein peak. Also, SePF activity was eluted at 0.4 M 
KCl, compared with 0.3 M KC1 for EF-1~. Although we 
could not completely separate SePF activity from EF- 1 dl 
activity, this result strongly suggests that the factor in 
fractions 30-38, and not EF-la, protected [‘%e]SeCys- 
tRNA against alkaline hydrolysis. One mg of protein in 
fraction 35 protected 4.2 pmol [“Se]SeCys-tRNA in the 
SePF assay system. 
In order to confirm that SePF and EF-l& are two 
distinct factors, we measured SePF activity in a sample 
of pure EF-la from Bombyx mori [16]. Fig. 5 shows the 
TLC [“Se]SeCys autoradiography results. Lane 1 is the 
result of fraction 35 of CM-Sephadex C-25 chromatogra- 
phy, and lane 2 is that of EF-la from B. mori. We 
detected a dense band of [7%e]SeCys only in lane 1, while 
lane 2 showed the same level as that in lane ‘No’ 
Fraction number 
Fig. 3. A chromatography pattern of the S-l fraction indicated in 
Fig. 1, using CM-Sephadex C-25. 0, EF-la activity (pmol/mg protein); 
l , SePF activity (pmollmg protein). Dashed line shows linear gradient 
of KCl. 
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Fig. 4. [75Se]SeCys-tRNA protecting activity of the eluates shown in Fig. 3. The results of autoradiography with the Bioimage Analyzer BAS2000 
are shown. Numbers indicate fraction numbers as plotted in Fig. 3. ‘No’ indicates control without added protein. ‘Co’ indicates control without 
alkaline hydrolysis. 
(no-protein control), and pure EF-la (lane 2) did not 
show any SePF activity. Pure EF-I& from B. mori had 
very strong EF-la activity (about l,OOO-fold higher than 
that of fraction 25 from CM-Sephadex C-25 chromatog- 
raphy) in this bovine EF-la assay system, and bovine 
and B. mori EF-la are structurally and functionally ho- 
mologous. Since EF-la from B. mori had no SePF activ- 
ity, we concluded that the factor protecting [“Se]SeCys- 
tRNA against alkaline hydrolysis is not EF-la. 
4. Discussion 
We searched for a SELB-like factor in bovine liver 
extracts and found a [“Se]SeCys-tRNA protecting activ- 
ity against alkaline hydrolysis. We showed that this ac- 
tivity did not depend upon EF-la, based on two main 
results. This activity was eluted after the peak of EF-la 
activity from a CM-Sephadex C-25 column (Fig. 3) and 
was found in fractions different from those containing 
the highest level of EF-la activity. We used EF-la from 
B. mori as an EF-l& control in the SePF assay, and 
found that EF-la from B. mori had little SePF activity 
(Fig. 5). EF-la’s among eukaryotes are highly similar, 
both in amino acid sequence @O-90% homology) [17] 
and in function. Since EF-ld from B. mori shows very 
strong EF- l& activity in our bovine EF- la assay system, 
we concluded that EF-la from B. mori is a valid control 
in our assay system. 
Although SePF activity (protecting activity) cannot be 
compared directly with EF- lee activity (binding activity), 
based on our results we estimate that SePF may occur 
as less than 2% of total EF-la in microsomal bovine liver 
extracts. We used microsomal fractions as a source of 
SePF, and it is possible that SePF may be present in 
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Fig. 5. (“Se]SeCys-tRNA protecting activity of pure EF-la from 
Bombyx mori. The results of autoradiography with the Bioimage Ana- 
lyzer BAS2000 are shown. Lane 1 is the active fraction of SePF ob- 
tamed from CM-Sephadex C-25 chromatography. Lane 2 is that of 
EF-la from B. mori. ‘No’ indicates control without added protein. 
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Fig. 6. Model for selenocysteine incorporation in eukaryotes. The SECIS factor is not identified. 
It is possible that this SePF activity is dependent upon 
other proteins related to SeCys-tRNA. These enzymes, 
such as SerRS, SeCys synthase and tRNA kinase, have 
little affinity for CM-Sephadex, although we found SePF 
activity in the high-affinity fraction (0.4 M KCl) after 
CM-Sephadex chromatography. Moreover, the molecu- 
lar mass of SePF is not identical to that of these enzymes 
(65, 70 and 450 kDa, respectively); therefore, we can 
exclude the possibility that SePF activity is dependent 
upon these enzymes. 
The isoelectric point of EF-la is 9-10 [16] due to a 
high content of basic amino acids, and therefore EF-la 
has a high affinity for CM-Sephadex (cation exchanger). 
Due to this basic property, EF-1~ easily binds ami- 
noacyl-tRNA. The SePF described in this paper also has 
a high affiity for CM-Sephadex and may have a basic 
isoelectric point, allowing it to bind [‘%e]SeCys-tRNA. 
However, tRNA_” has an abnormally long 9 bp accep- 
tor stem [18] which may not be protected by EF-l& itself 
and may require an additional elongation factor for pro- 
tection. The SePF described in the present report is a 
possible candidate. A model for SeCys incorporation in 
eukaryotes is shown in Fig. 6. 
Gelpi et al. reported a protein binding tRNA_ in 
humans [ 191 This protein was precipitated by the anti- 
bodies from autoimmune disease (chronic active hepati- 
tis) patients, and has a 48 kDa molecular mass. The SePF 
described in the present report has a similar molecular 
mass (approximately 50 kDa), and it is possible that 
SePF is the same protein as that identified by Gelpi et al. 
On E. cd FDH mRNA, the information for UGA- 
SeCys decoding is present on the stem-loop structure 
downstream of the UGA codon. In mammals, it has been 
proposed that the selenocysteine insertion sequence 
(SECIS) elements are present in the 3’ untranslated re- 
gion of type-l iodothyronine deiodinase (5’ DI) and se- 
lenoprotein P [20]. Since these elements are located far 
from the SeCys-UGA codon, a mechanism linking 
SECIS elements with the SeCys-UGA codon is neces- 
sary. SELB in E. coli play a role in this mechanism and 
consists of two regions. One is the EF-Tu-like region, 
and the other is the region involved in stem-loop recog- 
nition; thus, SELB has a larger molecular mass (68 kDa) 
than EF-Tu (42 kDa) [9]. SePF described in this report 
has a similar size to EF-la and most likely does not 
contain a region for SECIS element recognition. There- 
fore, we conclude that a factor (SECIS factor in Fig. 6) 
in addition to SePF is needed for recognition of the 
unknown UGA-SeCys decoding information in eukar- 
yotes. 
Acknowledgements: We thank Mr. Seiei Ikeda for preparation of 
tRNAs”cr” and Mr. Hirofumi Kondoh for invaluable discussion. 
References 
[l] Forstrom, J.W., Zakowski, J.J. and Tappel, A.L. (1978) Biochem- 
istry 17, 2639-2644. 
[2] Berry, M.J., Banu, L. and Larson, P.R. (1991) Nature 349,438 
[3] g, K.E., Lloyd, R.S., Yang, J.G., Read, R. and Burk, R.F. 
(1991) J. Biol. Chem. 266, 10050- 10053. 
142 K. Yam& et al. IFEBS Letters 347 (1994) 137-142 
[4] Mizutani, T., Kurata, H. and Yamada, K. (1991) FEBS Lett. 289, 
59-63. 
[5] Mizutani, T., Kurata, H., Yamada, K. and Tot&a, T. (1992) 
Biochem. J. 284, 827-834. 
[6] Zinioni, F., Birkmann, A., Stadtman, T.C. and Bock, A. (1986) 
Proc. Natl. Acad. Sci. USA 83,4650-4654. 
[7] For&hammer, K. and Bock, A. (1991) J. Biol. Chem. 266, 6324 
6328. 
[8] For&hammer, K., Rticknzgel, K. and Bock, A. (1990) J. Biol. 
Chem. 265, 93469350. 
[V] Baron, C., Heider, J. and Bock, A. (1993) Proc. Natl. Acad. Sci. 
USA 90, 4181-4185. 
[lo] Baron, C. and Bock, A. (1991) J. Biol. Chem. 266,20375-20379. 
[l l] Narihara, T., Fujita, Y. and Mizutani, T. (1982) J. Chromatogr. 
236, 513-518. 
[12] Mizutani, T., Narihara, T. and Hashimoto, A. (1984) Eur. J Bio- 
them. 143,9-13. 
[13] Ganther, H.E. (1971) Biochemistry 10, 40894098. 
[14] Nagata, S., Iwasaki, K. and Kaziro, Y. (1977) J. Biochem. 82, 
1633-1646. 
[15] Weissbach, H., Redfield, B. and Moon, H. (1973) Arch. B&hem. 
Biophys. 156, 267-275. 
[16] Ejiri, S. (1986) Methods Enzymol. 118, 140-153. 
[17] Lee, S., Francoeur, A.M., Liu, S. and Wang, E. (1992) J. Biochem. 
267, 24064-24068. 
[18] Sturchler, C., Westhof, E., Carbon, P. and Krol, A. (1993) Nucleic 
Acids Res. 21, 1073-1079. 
[19] Gelpi, C., Sontheimer, E.J. and Rodriguez-Sanchez, J.L. (1992) 
Proc. Natl. Acad. Sci. USA 89,9739-9743. 
[20] Hill, K.E., Lloyd, R.S. and Burk, R.F. (1993) Proc. Natl. Acad. 
Sci. USA 90, 537-541. 
